Back to Search Start Over

DNA Repair and Cell Cycle Control Genes and the Risk of Young-Onset Lung Cancer

Authors :
Debora Landi
David Zaridze
Paul Brennan
Lydie Gioia-Patricola
Eleonora Fabianova
Federico Canzian
Janet E. Hall
Peter Rudnai
Paolo Boffetta
Vladimir Janout
Dana Mates
Neonilia Szeszenia-Dabrowska
Vladimir Bencko
Federica Gemignani
Rayjean J. Hung
Jolanta Lissowska
Roberto Barale
Lenka Foretova
Valerie Gaborieau
Stefano Landi
Landi, S.
Gemignani, F.
Canzian, F.
Gaborieau, V.
Barale, R.
Landi, D.
Szeszenia-Dabrowska, N.
Zaridze, D.
Lissowska, J.
Rudnai, P.
Fabianova, E.
Mates, D.
Foretova, L.
Janout, V.
Bencko, V.
Gioia-Patricola, L.
Hall, J.
Boffetta, P.
Hung, R.J.
Brennan, P.
Source :
Cancer Research. 66:11062-11069
Publication Year :
2006
Publisher :
American Association for Cancer Research (AACR), 2006.

Abstract

Exposure to tobacco smoke and to mutagenic xenobiotics can cause various types of DNA damage in lung cells, which, if not corrected by DNA repair systems, may lead to deregulation of the cell cycle and, ultimately, to cancer. Genetic variation could thus be an important factor in determining susceptibility to tobacco-induced lung cancer with genetic susceptibility playing a larger role in young-onset cases compared with that in the general population. We have therefore studied 102 single-nucleotide polymorphisms (SNP) in 34 key DNA repair and cell cycle control genes in 299 lung cancer cases diagnosed before the age of 50 years and 317 controls from six countries of Central and Eastern Europe. We have found no association of lung cancer risk with polymorphisms in genes related to cell cycle control, single-strand/double-strand break repair, or base excision repair. Significant associations (P < 0.05) were found with polymorphisms in genes involved in DNA damage sensing (ATM) and, interestingly, in four genes encoding proteins involved in mismatch repair (LIG1, LIG3, MLH1, and MSH6). The strongest associations were observed with heterozygote carriers of LIG1 −7C>T [odds ratio (OR), 1.73; 95% confidence interval (95% CI), 1.13-2.64] and homozygote carriers of LIG3 rs1052536 (OR, 2.05; 95% CI, 1.25-3.38). Consideration of the relatively large number of markers assessed diminishes the significance of these findings; thus, these SNPs should be considered promising candidates for further investigation in other independent populations. (Cancer Res 2006; 66(22): 11062-9)

Details

ISSN :
15387445 and 00085472
Volume :
66
Database :
OpenAIRE
Journal :
Cancer Research
Accession number :
edsair.doi.dedup.....06599cb6480ef0ef9da58c7e65cb2967
Full Text :
https://doi.org/10.1158/0008-5472.can-06-1039